Literature DB >> 22990532

Prognostic factors for melanoma progression and metastasis: from Hematoxylin-Eosin to genetics.

A Fernandez-Flores1.   

Abstract

Researchers have searched for factors that predict the metastatic potential of melanomas for decades. In recent years, the study of their metastatic potential has progressed from routine histological analysis of Hematoxylin-Eosin stained slides to proteomic, genetic, and molecular pathological analyses. As a result, knowledge about the metastatic potential of melanomas has progressed. Hundreds of prognostic factors have been described in literature and it is not possible to mention all of them in a report. Therefore, in the current report, we summarize some of them.

Entities:  

Mesh：

Year:  2012        PMID： 22990532

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN： 1220-0522            Impact factor:   1.033


  7 in total

1.  Improving Melanoma Path Reports: the Importance of Histopathological Parameters in Diagnosis of Cutaneous Melanoma.

Authors:  Alina Mariana Avram; Olga Dana Simionescu; Mariana Costache; Mariana Grigore
Journal:  Maedica (Buchar)       Date:  2015-09

2.  Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.

Authors:  Sanxiong Xu; Zuozhang Yang; Jinyu Zhang; Yongxin Jiang; Yongbin Chen; Hongjun Li; Xuefeng Liu; Da Xu; Yanjin Chen; Yihao Yang; Ya Zhang; Dongxu Li; Junfeng Xia
Journal:  DNA Cell Biol       Date:  2015-01       Impact factor: 3.311

3.  Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients.

Authors:  Kai Zhang; Tienian Zhu; Dongmei Gao; Yimei Zhang; Qinglan Zhao; Shuang Liu; Tongyi Su; Michel Bernier; Ruijing Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-08       Impact factor: 4.553

4.  Expression of novel cancer/testis antigen TMEM31 increases during metastatic melanoma progression.

Authors:  Jiaqiang Li; Xiaowen Zou; Cailing Li; Jianhua Zhong; Yan Chen; Xiaoyue Zhang; Fuming Qi; Mengshuo Li; Zhiming Cai; Aifa Tang
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

Review 5.  Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

Authors:  Amy A Mrazek; Celia Chao
Journal:  Surg Clin North Am       Date:  2014-08-05       Impact factor: 2.741

6.  Proteomic analysis of proton beam irradiated human melanoma cells.

Authors:  Sylwia Kedracka-Krok; Urszula Jankowska; Martyna Elas; Urszula Sowa; Jan Swakon; Agnieszka Cierniak; Pawel Olko; Bozena Romanowska-Dixon; Krystyna Urbanska
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

Review 7.  Mucosal melanomas in the elderly: challenging cases and review of the literature.

Authors:  Flavia Baderca; Dana Vincze; Nicolae Balica; Caius Solovan
Journal:  Clin Interv Aging       Date:  2014-06-12       Impact factor: 4.458
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.